{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-018843","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2022-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.618690+00:00","generated_at":"2026-06-21T01:40:10.128827+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ReShape Lifesciences shareholders approve 2022 equity plan, reverse split, authorized share increase","bullets":["Stockholders approved 2022 Equity Incentive Plan with 5,250,000 shares available; effective through Dec 13, 2032.","Authorized reverse stock split at ratio 1:30 to 1:100, at Board's discretion, valid until Dec 14, 2023.","Increased authorized common shares to 300,000,000 shares from prior limit.","Elected Paul F. Hickey as Class III director; votes for 5,366,444 vs withheld 580,976.","Ratified RSM US LLP as independent auditor for FY2022; votes for 13,866,558."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-018843","json":"https://secwatch.observer/filing/0001558370-22-018843.json","markdown":"https://secwatch.observer/filing/0001558370-22-018843.md","text":"https://secwatch.observer/filing/0001558370-22-018843.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/0001558370-22-018843-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/rsls-20221214x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T01:40:10.128827+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0d86a4a5f0d063db916006db83ae2d10be0ae435","claim":"Vyome Holdings, Inc shareholders approved Amendment to Article IV, Section 1 of the Certificate of Incorporation to increase authorized common stock to 300,000,000 shares at the 2022-12-14 meeting.","evidence_excerpt":"The Company’s stockholders approved an amendment to Article IV, Section 1 of the Certificate of Incorporation to increase the number of shares of common stock authorized for issuance to 300,000,000 shares, as set forth below. Votes For Votes Against Abstentions 72,167,316 ​ 17,231,487 ​ 29,146","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/0001558370-22-018843-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-14"}],"fact_type":"shareholder_vote"},{"claim_id":"1c7271f739294185dc7d6c10e9baa4c2ab04ab2f","claim":"Vyome Holdings, Inc shareholders approved Authorization to amend Certificate of Incorporation to effect a reverse stock split at a ratio in the range of 1-for-30 to 1-for-100 at the 2022-12-14 meeting.","evidence_excerpt":"The Company’s stockholders authorized the Board, in its discretion but in no event later than December 14, 2023, which is one year after the date of the Annual Meeting, to amend the Company’s Certificate of Incorporation to effect a reverse stock split of the Company’s common stock, at a ratio in the range of 1-for-30 to 1-for-100, such ratio to be determined by the Board and included in a public announcement, as set forth below. Votes For Votes Against Abstentions 73,383,162 ​ 13,008,564 ​ 36,223","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/0001558370-22-018843-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-14"}],"fact_type":"shareholder_vote"},{"claim_id":"b42ffffa37de214a3400ab6de0828b21a76047c7","claim":"Vyome Holdings, Inc shareholders approved Election of Paul F. Hickey as a Class III director at the 2022-12-14 meeting.","evidence_excerpt":"The Company’s stockholders elected Paul F. Hickey as a Class III director to hold office until the 2025 annual meeting of stockholders or until his successor is elected and qualified, or, if sooner, until his death, resignation or removal, as set forth below. Votes For Votes Withheld Broker Non-Votes 5,366,444 ​ 580,976 ​ 8,480,529","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/0001558370-22-018843-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-14"}],"fact_type":"shareholder_vote"},{"claim_id":"c04ac1bfeffcd2ea8b35d3772704af3bd2e4c569","claim":"Vyome Holdings, Inc shareholders approved Approval of the ReShape Lifesciences Inc. 2022 Equity Incentive Plan at the 2022-12-14 meeting.","evidence_excerpt":"The Company’s stockholders approved the ReShape Lifesciences Inc. 2022 Equity Incentive Plan, as set forth below. Votes For Votes Against Abstentions Broker Non-Votes 3,721,022 ​ 2,142,351 ​ 84,047 ​ 8,480,529","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/0001558370-22-018843-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-14"}],"fact_type":"shareholder_vote"},{"claim_id":"ce8ec2fb635baa8e981916bd51057dca4d2e8db6","claim":"Vyome Holdings, Inc shareholders approved Ratification of appointment of RSM US LLP as independent registered public accounting firm for fiscal year ending December 31, 2022 at the 2022-12-14 meeting.","evidence_excerpt":"The Company’s stockholders ratified the appointment of RSM US LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022, as set forth below. Votes For Votes Against Abstentions 13,866,558 ​ 417,065 ​ 144,326","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/0001558370-22-018843-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-14"}],"fact_type":"shareholder_vote"},{"claim_id":"d46f385bfd8fea69c5bde4ab58d3dae2c9c47604","claim":"Vyome Holdings, Inc shareholders approved Advisory vote on compensation of named executive officers at the 2022-12-14 meeting.","evidence_excerpt":"The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as set forth below. Votes For Votes Against Abstentions Broker Non-Votes 4,054,583 ​ 1,837,687 ​ 55,150 ​ 8,480,529","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1427570/000155837022018843/0001558370-22-018843-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-14"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}